You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucagon

Showing 26 - 50 of 2,606
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Chronic Kidney Diseases, Liver Cirrhosis, Hyperglucagonemia Trial in Hellerup (Glucagon infusion, Primed tracer infusion)

Recruiting
  • Chronic Kidney Diseases
  • +2 more
  • Glucagon infusion
  • Primed tracer infusion
  • Hellerup, Copenhagen, Denmark
    Center for Clinical Metabolic Research, Department of Medicine,
Mar 25, 2022

Type 1 Diabetes, Hypoglycemia Trial in Gentofte (GlucaGen, Saline)

Recruiting
  • Type 1 Diabetes
  • Hypoglycemia
  • Gentofte, Denmark
    Sissel Banner Lundemose
May 4, 2022

Type1 Diabetes Trial in Baltimore (Glucagon-like peptide-1, Placebos)

Recruiting
  • Type1 Diabetes Mellitus
  • Glucagon-like peptide-1
  • Placebos
  • Baltimore, Maryland
    University of Maryland
Apr 8, 2022

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Al Ain, Abu Dhabi, United Arab Emirates
    Internal Medicine, College of Medicine and Health Sciences
Mar 1, 2023

Hypoglycemic Risk in Type 1 Diabetes

Not yet recruiting
  • Type 1 Diabetes
  • Hypoglycemia
  • Mixed Meal Tolerance Test (MMTT)
  • +2 more
  • Exeter, Devon, United Kingdom
    Royal Devon University Healthcare NHS Foundation Trust
Dec 19, 2022

Asthma Trial in Nashville (Semaglutide Pen Injector 2.4mg weekly, Placebo)

Not yet recruiting
  • Asthma
  • Semaglutide Pen Injector 2.4mg weekly
  • Placebo
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 22, 2022

Healthy Participants Trial in New Haven (Glucagon)

Active, not recruiting
  • Healthy Participants
  • Glucagon
  • New Haven, Connecticut
    Yale Hospital reserach Unit / YCCI
Jan 17, 2022

Hyperlipidemias Trial in Toronto (Teduglutide, Placebo)

Completed
  • Hyperlipidemias
  • Toronto, Ontario, Canada
  • +1 more
May 18, 2022

Diabetes, Type 1, Hypoglycemia Trial in Québec (Videos, Simulation, Interview)

Recruiting
  • Diabetes Mellitus, Type 1
  • Hypoglycemia
  • Videos
  • +2 more
  • Québec, Canada
    Centre de recherche du CHU de Québec - Université Laval
May 26, 2022

Type 1 Diabetes Trial in Charlottesville (Basal insulin alone, Basal pramlintide and reduced basal insulin, CGM)

Terminated
  • Type 1 Diabetes Mellitus
  • Basal insulin alone
  • +5 more
  • Charlottesville, Virginia
    University of Virginia Center for Diabetes Technology
Mar 10, 2022

Sexual Functioning Trial in Basel (Dulaglutide, Placebo)

Recruiting
  • Sexual Functioning
  • Basel, Switzerland
    University Hospital Basel, Endocrinology, Diabetes and Metabolis
Mar 3, 2022

Obesity Trial in Orlando (Glucagon, Placebo)

Active, not recruiting
  • Obesity
  • Glucagon
  • Placebo
  • Orlando, Florida
    Translational Research Institute for Metabolism and Diabetes
Oct 5, 2021

Hypopituitarism Trial in Torino (Intranasal glugagon, Intranasal )

Completed
  • Hypopituitarism
  • Intranasal glugagon
  • Intranasal placebo
  • Torino, Piemonte, Italy
    AOU Città della Salute e della Scienza
Jan 11, 2022

Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

Not yet recruiting
  • Insulin Resistance
  • +3 more
  • Insulin human
  • +11 more
  • New York, New York
    Columbia University Irving Medical Center
Nov 6, 2023

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Obesity Trial in Mansourah, Mansoura (Liraglutide)

Recruiting
  • Obesity
  • Mansourah, Dakhlia, Egypt
  • +1 more
Feb 24, 2022

Type 1 Diabetes Trial in United States (Glucagon Nasal Powder [Baqsimi])

Recruiting
  • Type 1 Diabetes
  • Glucagon Nasal Powder [Baqsimi]
  • Los Angeles, California
  • +8 more
Apr 6, 2022

Wolfram Syndrome Trial (Tirzepatide)

Not yet recruiting
  • Wolfram Syndrome
  • (no location specified)
Dec 12, 2022

Type 1 Diabetes, Hypoglycemia Trial in Gentofte (Glucagon, Closed-loop system)

Completed
  • Type 1 Diabetes
  • Hypoglycemia
  • Glucagon
  • Closed-loop system
  • Gentofte, Denmark
    Steno Diabetes Center Copenhagen
Aug 17, 2022

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Type1diabetes Trial in Boston (Very low carbohydrate diet)

Recruiting
  • Type1diabetes
  • Very low carbohydrate diet
  • Boston, Massachusetts
    Boston Children's Hospital
Nov 2, 2021

Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • San Antonio, Texas
    Texas Diabetes Institute
Dec 22, 2021

Type 1 Diabetes, Type 1 Diabetes With Hypoglycemia, Hypoglycemia Trial in Edinburgh (procedure, device, other)

Recruiting
  • Type 1 Diabetes
  • +5 more
  • Stepped hyperinsulinaemic-hypoglycaemic clamp study
  • +5 more
  • Edinburgh, United Kingdom
    Edinburgh Royal Infirmary/University of Edinburgh
Jan 13, 2022

Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)

Not yet recruiting
  • Kidney Transplant Recipients
  • Dapagliflozin 10 MG
  • Semaglutide, 1.0 mg/mL
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jul 6, 2023